US 10087211
Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties
granted A61PA61P25/00A61P25/02
Quick answer
US patent 10087211 (Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61P, A61P25/00, A61P25/02, A61P25/08, A61P25/22